近距離放射治療的美國市場(2021年∼2027年)

美國的近距離放射治療的市場規模，2020年是3億4,740萬美元，在預測期間(2021年∼2027年)預計以3.1％的年複合成長率成長。

美國，由於研究開發的投資，高醫療費，主要企業的存在，癌症患者增加等各式各樣的因素，成為近距離放射治療的主要市場。癌症的罹患率高，促進美國的近距離放射治療市場成長。還有市場參與企業，為了維持市場上的競爭力，驅使M&A和共同研究等各種策略，對市場成長有大幅貢獻。

本報告提供美國的近距離放射治療市場相關調查分析，市場概要，市場趨勢，競爭情形，市場分析，企業簡介等系統性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

• 調查範圍
• 分析師的洞察和目前市場趨勢

第3章 市場決策要素

• 促進因素
• 阻礙因素
• 市場機會

第4章 市場細分化

• 美國的近接治療市場:各症狀
  • 乳癌
  • 婦產科癌症
  • 前列腺癌症
  • 皮膚癌症
  • 腦瘤
  • 其他
• 美國的近接治療市場:各類型
  • 低劑量率(LDR)近距離放射療法
  • 高線量率(HDR)近距離放射療法

第5章 企業簡介

• AngioDynamics, Inc.
• Becton, Dickinson and Co.
• Best Medical International, Inc.
• Boston Scientific Corp.
• C4 Imaging LLC
• CIVCO Medical Solutions
• General Electric Co.
• Hologic, Inc.
• iCAD, Inc.
• Isoaid, LLC
• Isoray, Inc.
• Merit Medical Systems, Inc.
• Sensus Healthcare, Inc.
• Sun Nuclear Corp.
• Varian Medical Systems, Inc.

US Brachytherapy Market Size, Share &Trends Analysis Report by Indication (Breast Cancer, Gynecological Cancer, Prostate Cancer, Skin Cancer, Brain Cancer, and Others), and by Type (Low-Dose Rate (LDR) Brachytherapy and High-Dose Rate (HDR) Brachytherapy) Forecast Period, 2020-2027

The US brachytherapy market is anticipated to grow at a substantial CAGR of 3.1% during the forecast period. The market was valued at $347.4 million in 2020. The US is the major market of brachytherapy due to various factors such as investments in R&D, high healthcare expenditure, the presence of key players, and the rising prevalence of cancer patients. The high prevalence of cancer has contributed to the growth of the US brachytherapy market. According to the American Cancer Society in 2019, around 1.8 million new cases were recorded and 891,480 people died in the US due to cancer, around 200,500 would be caused by cigarette smoking. According to the American Cancer Society in 2019, 85% of all cancers in the US were diagnosed in people of age group 50 and above.

The US brachytherapy market is segmented based on indication and type. Based on indication, the brachytherapy market is segmented into breast cancer, gynecological cancer, prostate cancer, skin cancer, brain cancer, and others. Prostate cancer held a major share in the region as according to the American Cancer Society, 1 in 9 men are likely to be diagnosed with prostate cancer during their lifetime. While 1 in 39 men dies with this disease. Based on type, the brachytherapy market is segmented into LDR and HDR.

Some of the major companies serving the US brachytherapy market include AngioDynamics, Inc., General Electric Co., Hologic, Inc., Isoray, Inc., Sensus Healthcare, Inc., Sun Nuclear Corp., and others. The market players are considerably contributing to the market growth by adopting various strategies including mergers and acquisitions, collaborations, to stay competitive in the market

Additionally, various organizations are involved in the R&D of brachytherapy and its application in different cancers. For instance, the UCLA Brachytherapy Division is one of the most experienced and advanced centers in the US that have expertise in using brachytherapy to treat all types of cancers. The center has state-of-the-art equipment and facilities including a brachytherapy suite in the Department of Radiation Oncology, a portable CT scanner for imaging during implants, real-time ultrasound planning for prostate brachytherapy, a new Flexitron afterloader, and a Xoft unit for intraoperative breast radiation.

Research Methodology

The market study of the US brachytherapy market is incorporated by extensive primary and secondary research conducted by the research team at OMR Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market

Whitepapers, research papers, and news blogs

Company websites and their product catalog

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

US Brachytherapy Market Research and Analysis by Indication

US Brachytherapy Market Research and Analysis by Type

The Report Covers

Comprehensive research methodology of the US brachytherapy market

This report also includes a detailed and extensive market overview with key analyst insights

An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations

Analysis of regional regulations and other government policies impacting the US brachytherapy market

Insights about market determinants that are stimulating the US brachytherapy market

Detailed and extensive market segments with the regional distribution of forecasted revenues

Extensive profiles and recent developments of market players

Table of Contents

1. Report Summary

• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. BY Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Market Determinants

• 3.1. Motivators
• 3.2. Restraints
• 3.3. Opportunities

4. Market Segmentation

• 4.1. US Brachytherapy Market by Indication
  • 4.1.1. Breast Cancer
  • 4.1.2. Gynecological Cancer
  • 4.1.3. Prostate Cancer
  • 4.1.4. Skin Cancer
  • 4.1.5. Brain Cancer
  • 4.1.6. Others
• 4.2. US Brachytherapy Market by Type
  • 4.2.1. Low-Dose Rate (LDR) Brachytherapy
  • 4.2.2. High-Dose Rate (HDR) Brachytherapy

5. Company Profiles

• 5.1. AngioDynamics, Inc.
• 5.2. Becton, Dickinson and Co.
• 5.3. Best Medical International, Inc.
• 5.4. Boston Scientific Corp.
• 5.5. C4 Imaging LLC
• 5.6. CIVCO Medical Solutions
• 5.7. General Electric Co.
• 5.8. Hologic, Inc.
• 5.9. iCAD, Inc.
• 5.10. Isoaid, LLC
• 5.11. Isoray, Inc.
• 5.12. Merit Medical Systems, Inc.
• 5.13. Sensus Healthcare, Inc.
• 5.14. Sun Nuclear Corp.
• 5.15. Varian Medical Systems, Inc.

LIST OF TABLES

• 1. US BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2020-2027 ($ MILLION)
• 2. US BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)

LIST OF FIGURES

• 1. US BRACHYTHERAPY MARKET SHARE BY INDICATION, 2020 VS 2027 (%)
• 2. US BRACHYTHERAPY MARKET SHARE BY TYPE, 2020 VS 2027 (%)
• 3. US BRACHYTHERAPY MARKET SIZE, 2020-2027 ($ MILLION)